These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


444 related items for PubMed ID: 20172281

  • 21. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC, Huang JL, Chang CJ, Kong MS.
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [Abstract] [Full Text] [Related]

  • 22. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 23. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A, Douglas S, Rogers MA, Arnott ID, Plevris JN.
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [Abstract] [Full Text] [Related]

  • 24. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS.
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [Abstract] [Full Text] [Related]

  • 25. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Paraskeva P, Tekkis PP.
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [Abstract] [Full Text] [Related]

  • 27. [Measurement of calprotectin in faeces].
    Jahnsen J, Røseth AG, Aadland E.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):743-5. PubMed ID: 19373299
    [Abstract] [Full Text] [Related]

  • 28. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants.
    Campeotto F, Baldassarre M, Butel MJ, Viallon V, Nganzali F, Soulaines P, Kalach N, Lapillonne A, Laforgia N, Moriette G, Dupont C, Kapel N.
    J Pediatr Gastroenterol Nutr; 2009 Apr 16; 48(4):507-10. PubMed ID: 19322064
    [Abstract] [Full Text] [Related]

  • 29. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
    Gundling F, Schmidtler F, Hapfelmeier A, Schulte B, Schmidt T, Pehl C, Schepp W, Seidl H.
    Liver Int; 2011 Oct 16; 31(9):1406-15. PubMed ID: 22093455
    [Abstract] [Full Text] [Related]

  • 30. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 16; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 31. Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline.
    Mercer DF.
    Curr Opin Organ Transplant; 2011 Jun 16; 16(3):316-22. PubMed ID: 21505339
    [Abstract] [Full Text] [Related]

  • 32. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW, Chen YS, de Villa VH, Wang CC, Eng HL, Wang SH, Liu PP, Jawan B, Huang TL, Cheng YF, Chen CL.
    Hepatogastroenterology; 2005 Jun 16; 52(66):1825-7. PubMed ID: 16334785
    [Abstract] [Full Text] [Related]

  • 33. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO.
    Scand J Gastroenterol; 2007 Oct 16; 42(10):1151-7. PubMed ID: 17852876
    [Abstract] [Full Text] [Related]

  • 34. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
    Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.
    Aliment Pharmacol Ther; 2008 Nov 15; 28(10):1221-9. PubMed ID: 18752630
    [Abstract] [Full Text] [Related]

  • 35. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May 15; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 36. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
    Joshi S, Lewis SJ, Creanor S, Ayling RM.
    Ann Clin Biochem; 2010 May 15; 47(Pt 3):259-63. PubMed ID: 19740914
    [Abstract] [Full Text] [Related]

  • 37. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
    Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M.
    Scand J Gastroenterol; 2012 Jul 15; 47(7):778-84. PubMed ID: 22519419
    [Abstract] [Full Text] [Related]

  • 38. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
    Husebye E, Tøn H, Johne B.
    Am J Gastroenterol; 2001 Sep 15; 96(9):2683-7. PubMed ID: 11569695
    [Abstract] [Full Text] [Related]

  • 39. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
    Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d'Elia H.
    Scand J Gastroenterol; 2012 Apr 15; 47(4):435-44. PubMed ID: 22229862
    [Abstract] [Full Text] [Related]

  • 40. [Pediatrics. Fecal calprotectin in children: use and interpretation].
    Ezri J, Nydegger A.
    Rev Med Suisse; 2011 Jan 12; 7(277):69-70. PubMed ID: 21309180
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.